US Stock MarketDetailed Quotes

HSDT Helius Medical Technologies

Watchlist
  • 0.7300
  • +0.0025+0.34%
Close Aug 23 16:00 ET
  • 0.7300
  • 0.00000.00%
Post 20:01 ET
2.61MMarket Cap-75P/E (TTM)

Helius Medical Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-28.91%182K
21.62%135K
-18.17%644K
-52.48%134K
-27.04%143K
115.13%256K
-41.58%111K
50.77%787K
9.30%282K
79.82%196K
Operating revenue
-29.92%171K
16.98%124K
-22.24%605K
-56.23%123K
-32.31%132K
105.04%244K
-42.08%106K
57.81%778K
11.95%281K
91.18%195K
Cost of revenue
-35.87%118K
0.82%123K
25.92%583K
-40.00%90K
85.15%187K
109.09%184K
-1.61%122K
55.37%463K
16.28%150K
17.44%101K
Gross profit
-11.11%64K
209.09%12K
-81.17%61K
-66.67%44K
-146.32%-44K
132.26%72K
-116.67%-11K
44.64%324K
2.33%132K
313.04%95K
Operating expense
1.31%3.33M
-9.77%3.43M
-18.25%12.33M
-18.24%2.29M
-29.61%2.95M
-4.91%3.29M
-17.95%3.8M
-17.88%15.08M
-33.80%2.8M
-4.66%4.19M
Selling and administrative expenses
-4.36%2.46M
-8.39%2.63M
-12.87%9.27M
-17.03%1.63M
-35.28%2.2M
4.39%2.57M
1.95%2.87M
-12.61%10.64M
-17.21%1.97M
18.68%3.39M
Research and development costs
27.19%870K
-11.06%788K
-30.97%2.94M
-18.14%650K
-3.86%722K
-28.23%684K
-49.77%886K
-28.85%4.26M
-56.08%794K
-49.56%751K
Depreciation amortization depletion
-81.58%7K
-82.05%7K
-35.36%117K
-80.00%8K
-31.91%32K
-19.15%38K
-17.02%39K
-9.50%181K
-14.89%40K
-2.08%47K
-Depreciation and amortization
-81.58%7K
-82.05%7K
-35.36%117K
-80.00%8K
-31.91%32K
-19.15%38K
-17.02%39K
-9.50%181K
-14.89%40K
-2.08%47K
Operating profit
-1.58%-3.27M
10.34%-3.42M
16.87%-12.27M
15.85%-2.25M
26.90%-2.99M
6.15%-3.22M
16.52%-3.81M
18.65%-14.76M
34.93%-2.67M
6.33%-4.1M
Net non-operating interest income expense
-105.62%-5K
-108.00%-8K
130.82%257K
0
107.40%68K
89K
100K
-834K
85K
-919K
Total other finance cost
105.62%5K
108.00%8K
-130.82%-257K
--0
-107.40%-68K
---89K
---100K
--834K
---85K
--919K
Other net income (expense)
12.21%1.66M
-25.33%908K
107.89%3.16M
152.17%1.2M
-118.49%-737K
490.00%1.48M
457.80%1.22M
15,110.00%1.52M
-2.3M
1,369.11%3.99M
Gain on sale of security
7.42%1.59M
-29.77%854K
42.71%3.24M
148.87%1.13M
-112.34%-585K
490.00%1.48M
460.37%1.22M
22,610.00%2.27M
---2.31M
1,610.19%4.74M
Special income (charges)
----
----
79.00%-159K
--0
79.00%-159K
----
----
---757K
--0
---757K
-Less:Impairment of capital assets
----
----
-79.00%159K
--0
-79.00%159K
----
----
--757K
--0
--757K
Other non- operating income (expenses)
--71K
--54K
1,042.86%80K
1,116.67%73K
--7K
----
----
--7K
--6K
----
Income before tax
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
Net income continuous Operations
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
Minority interest income
Net income attributable to the parent company
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.18%-1.61M
-0.88%-2.52M
37.11%-8.85M
78.61%-1.05M
-255.63%-3.66M
56.75%-1.65M
42.61%-2.49M
22.39%-14.07M
-19.11%-4.89M
78.02%-1.03M
Basic earnings per share
78.08%-0.64
30.32%-3.08
72.07%-14.56
88.71%-0.96
-89.31%-5.49
93.98%-2.92
92.31%-4.42
85.87%-52.13
87.02%-8.5
97.11%-2.9
Diluted earnings per share
78.08%-0.64
30.32%-3.08
72.07%-14.56
88.71%-0.96
-89.31%-5.49
93.98%-2.92
92.31%-4.42
85.87%-52.13
87.02%-8.5
97.11%-2.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -28.91%182K21.62%135K-18.17%644K-52.48%134K-27.04%143K115.13%256K-41.58%111K50.77%787K9.30%282K79.82%196K
Operating revenue -29.92%171K16.98%124K-22.24%605K-56.23%123K-32.31%132K105.04%244K-42.08%106K57.81%778K11.95%281K91.18%195K
Cost of revenue -35.87%118K0.82%123K25.92%583K-40.00%90K85.15%187K109.09%184K-1.61%122K55.37%463K16.28%150K17.44%101K
Gross profit -11.11%64K209.09%12K-81.17%61K-66.67%44K-146.32%-44K132.26%72K-116.67%-11K44.64%324K2.33%132K313.04%95K
Operating expense 1.31%3.33M-9.77%3.43M-18.25%12.33M-18.24%2.29M-29.61%2.95M-4.91%3.29M-17.95%3.8M-17.88%15.08M-33.80%2.8M-4.66%4.19M
Selling and administrative expenses -4.36%2.46M-8.39%2.63M-12.87%9.27M-17.03%1.63M-35.28%2.2M4.39%2.57M1.95%2.87M-12.61%10.64M-17.21%1.97M18.68%3.39M
Research and development costs 27.19%870K-11.06%788K-30.97%2.94M-18.14%650K-3.86%722K-28.23%684K-49.77%886K-28.85%4.26M-56.08%794K-49.56%751K
Depreciation amortization depletion -81.58%7K-82.05%7K-35.36%117K-80.00%8K-31.91%32K-19.15%38K-17.02%39K-9.50%181K-14.89%40K-2.08%47K
-Depreciation and amortization -81.58%7K-82.05%7K-35.36%117K-80.00%8K-31.91%32K-19.15%38K-17.02%39K-9.50%181K-14.89%40K-2.08%47K
Operating profit -1.58%-3.27M10.34%-3.42M16.87%-12.27M15.85%-2.25M26.90%-2.99M6.15%-3.22M16.52%-3.81M18.65%-14.76M34.93%-2.67M6.33%-4.1M
Net non-operating interest income expense -105.62%-5K-108.00%-8K130.82%257K0107.40%68K89K100K-834K85K-919K
Total other finance cost 105.62%5K108.00%8K-130.82%-257K--0-107.40%-68K---89K---100K--834K---85K--919K
Other net income (expense) 12.21%1.66M-25.33%908K107.89%3.16M152.17%1.2M-118.49%-737K490.00%1.48M457.80%1.22M15,110.00%1.52M-2.3M1,369.11%3.99M
Gain on sale of security 7.42%1.59M-29.77%854K42.71%3.24M148.87%1.13M-112.34%-585K490.00%1.48M460.37%1.22M22,610.00%2.27M---2.31M1,610.19%4.74M
Special income (charges) --------79.00%-159K--079.00%-159K-----------757K--0---757K
-Less:Impairment of capital assets ---------79.00%159K--0-79.00%159K----------757K--0--757K
Other non- operating income (expenses) --71K--54K1,042.86%80K1,116.67%73K--7K----------7K--6K----
Income before tax 2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M
Income tax 0000000000
Net income 2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M
Net income continuous Operations 2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M
Minority interest income
Net income attributable to the parent company 2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.18%-1.61M-0.88%-2.52M37.11%-8.85M78.61%-1.05M-255.63%-3.66M56.75%-1.65M42.61%-2.49M22.39%-14.07M-19.11%-4.89M78.02%-1.03M
Basic earnings per share 78.08%-0.6430.32%-3.0872.07%-14.5688.71%-0.96-89.31%-5.4993.98%-2.9292.31%-4.4285.87%-52.1387.02%-8.597.11%-2.9
Diluted earnings per share 78.08%-0.6430.32%-3.0872.07%-14.5688.71%-0.96-89.31%-5.4993.98%-2.9292.31%-4.4285.87%-52.1387.02%-8.597.11%-2.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg